KCAS Bio

KCAS Bio

GLP/GCP bioanalytical & biomarker CRO services

Overview

KCAS Bio is a full-service bioanalytical and biomarker contract research organization (CRO) that supports pharmaceutical, biotechnology, and academic clients by delivering GLP- and GCP-compliant development services for drugs, biologics, and cell/gene therapies. The company operates on a contract-based model, providing flexible, expert teams and scalable capacity to meet each project’s needs. Its workflow involves conducting bioanalytical assays and biomarker work within regulated frameworks, acting as an extension of clients’ laboratories to enable rapid, scientifically rigorous research. KCAS Bio differentiates itself through a collaborative culture, continuous learning, and a commitment to speed and adaptability, focusing on delivering high-quality results efficiently. The company’s goal is to help clients advance time-critical research and bring new therapies through development and regulatory stages quickly and confidently.

Significant Headcount Growth

About KCAS Bio

Simplify's Rating
Why KCAS Bio is rated
C
Rated C on Competitive Edge
Rated C on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

201-500

Company Stage

Seed

Total Funding

$250K

Headquarters

Olathe, Kansas

Founded

1979

Get referred to KCAS Bio

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • March 2026 Lyon GLP renewal strengthens IND-enabling credibility with regulators and sponsors.
  • September 2026 board additions Paul Kirchgraber and Kurt Doyle deepen commercial and operational oversight.
  • September 2026 event schedule shows active selling into vaccines, biologics, and precision medicine.

What critics are saying

  • Labcorp, SGS, QPS, and Altasciences compress pricing and chase the same sponsors.
  • KCAS Bio’s headcount fell 11% over one year, signaling weaker demand.
  • If Vitruvian exits without a buyer by 2027, growth capital dries up.

What makes KCAS Bio unique

  • KCAS Bio combines GLP and GCP bioanalysis across US, Lyon, and Australia.
  • The company touts globally harmonized Cytek spectral flow cytometers, unique among bioanalytical CROs.
  • Its 2026 portfolio spans LC-MS/MS, biomarkers, immunogenicity, and cell-based assays.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$250k

Below

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Below Average

Industry standards

$3.3M
$250k
KCAS Bio
$1.5M
Slack
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood

Benefits

Company Equity

Professional Development Budget

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

↑ 29%

1 year growth

↑ 29%

2 year growth

↑ 29%
KCAS Bio
Sep 10th, 2026
Biomarkers, CDx & Precision Medicine - Europe 2026.

Biomarkers, CDx & Precision Medicine - Europe 2026. October 13 2026 - October 14 2026 Join KCAS Bio at the Biomarkers, CDx & Precision Medicine -Europe 2026, taking place from October 13-14 in Basel, Switzerland. This European event unites pharma, biotech, and academic leaders to explore biomarker innovation, companion diagnostics, and precision medicine, with new 2026 tracks on spatial biology and computational pathology & AI. Kcas, Llc will be attending to connect with the biomarker and precision medicine community and discuss its bioanalytical services, from assay development to biomarker and CDx validation. Let's Connect at the Biomarkers, CDx & Precision Medicine Kcas, Llc invite you to connect with Kcas, Llc throughout the event. MAgali Roche, Ph.D is prepared to engage in discussions on any stage of therapeutic drug development. Date: October 13 - October 14 Address: Congress Centre Basel, Switzerland Add to calendar: Meet Kcas, Llc at this event By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Sep 3rd, 2026
KCAS Bio's Ryan Darling to present at SCIEX Summit 2026.

KCAS Bio's Ryan Darling to present at SCIEX Summit 2026. KCAS Bio's Ryan Darling, Associate Director of Mass Spectrometry Bioanalysis, will present at the SCIEX Summit 2026 on Wednesday, October 7, as part of Day 2 of the virtual event. Advancing ultrasensitive bioanalysis for complex modalities. Ryan's presentation, "Ultrasensitive multiplexed bioanalysis of complex modalities using the SCIEX 7500+ system: A CRO perspective," will explore how multiplexed LC-MS/MS workflows can support the sensitive quantitation of increasingly complex therapeutic modalities. His presentation will highlight approaches for analyzing antibody-drug conjugates (ADCs), antibody-oligonucleotide conjugates (AOCs), siRNAs, and other biotherapeutics, with a focus on improving analytical efficiency while reducing the overall burden of complex bioanalytical workflows. As therapeutic modalities continue to evolve, bioanalytical strategies must keep pace. Multiplexed workflows offer an opportunity to address challenging analytical requirements while generating high-quality data with greater efficiency. Join Ryan at SCIEX Summit 2026. Ryan will speak on Wednesday, October 7, during Day 2: Advancing therapeutic development through analytical science. The session will be part of a day focused on analytical approaches for complex pharmaceutical and biopharmaceutical challenges, including bioanalysis, oligonucleotide quantification, and ADC characterization. Register for SCIEX Summit 2026 and join Ryan and other industry experts for a closer look at emerging approaches in analytical science. Use the link above to register for the event. Or, fill out the form below to speak directly with a scientist from KCAS Bio. By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Jul 27th, 2026
World Vaccine Congress Europe.

World Vaccine Congress Europe. October 19 2026 - October 21 2026 KCAS Bio at the World Vaccine Congress - Europe 2026. KCAS Bio is thrilled to announce its participation in the World Vaccine Congress Europe, taking place in Amsterdam, Netherlands, from October 19-21. This event gathers the world's leading vaccine research, development, and manufacturing experts to share groundbreaking insights and advancements. Kcas, Llc is excited to join this dynamic forum and showcase its exceptional bioanalytical capabilities. At KCAS Bio, Kcas, Llc is dedicated to advancing vaccine development through its expertise in bioanalytical services. Its team of highly skilled scientists provides precise and reliable data to support all stages of vaccine research and development. From immunogenicity testing and neutralizing antibody assays to biomarker analysis and stability testing, its comprehensive suite of services ensures the highest standards of accuracy and efficiency. Its state-of-the-art laboratory facilities are equipped with the latest technologies to meet the evolving needs of the vaccine industry. Let's connect. Contact KCAS Bio to schedule a meeting at the World Vaccine Congress Europe. Let's discuss your project needs and explore how its innovative services can drive your success. Reach out to Kcas, Llc today or directly to Charisse Fernandez. Date: October 19 - October 21 Address: RAI Amsterdam Convention Centre, Amsterdam Add to calendar: Meet Kcas, Llc at this event By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Jul 27th, 2026
Festival of Biologics 2026.

Festival of Biologics 2026. October 13 2026 - October 15 2026 Join KCAS Bio at the 2026 Festival of Biologics, taking place from October 13-15 in Basel, Switzerland. This festival, hosted by Terrapinn, brings together global stakeholders across pharma, biotech, academia, regulation, and investment to explore the discovery, development, manufacturing and commercialization of biologic therapies. During presentations, panels, workshops, and roundtables, experts will share insights on antibody therapies, cell and gene therapies, immunotherapies, and biosimilars. The event will foster in-depth conversations on cutting-edge developments in this field. Driving innovation in biologics at KCAS Bio. KCAS Bio is an industry leader across the biologics and advanced therapies landscape, delivering services that bring complex large molecule therapies to life. Its antibody drug conjugates, cell and gene therapies, immunotherapies, and other biologics expertise supports clients' endeavors from early discovery through clinical development. Kcas, Llc provide integrated bioanalytical, biomarker, and cell-based assay services that address the scientific and logistical challenges of modern therapeutic development, helping programs advance efficiently with confidence. As the industry evolves, Kcas, Llc remain committed to enabling progress through adaptable, science-driven solutions at every stage of the therapeutic lifecycle. Let's connect at the Festival of Biologics 2026. Kcas, Llc invite you to connect with Kcas, Llc throughout the festival. Gregoire Tauveron, Ph.D. is prepared to engage in discussions on any stage of therapeutic drug development. Date: October 13 - October 15 Address: Hall 1, Messe Basel Basel, Switzerland Add to calendar: Meet Kcas, Llc at this event By submitting this form, you acknowledge that KCAS Bio will use the information provided to respond to your inquiry. Please see its Privacy Policy for information about how Kcas, Llc process your personal data.

KCAS Bio
Jul 21st, 2026
ESCGT Annual Congress.

ESCGT Annual Congress. October 27 2026 - October 30 2026 KCAS Bio at the 33rd ESCGT Annual Congress. KCAS Bio will be attending the ESGCT 33rd Annual Congress on October 27th-30th in Hamburg, Germany. Held in collaboration with DG-GT, this congress brings together experts, researchers, and professionals in gene and cell therapy to share the latest research, advancements, and innovations in the field. This event is a valuable opportunity to connect with the broader cell and gene therapy community and discuss emerging science shaping the sector. Let's connect. Heading to Hamburg for ESGCT? Let's connect - get in touch to set up a meeting with its team while Kcas, Llc is both there. you can use the contact form or directly reach out to Charisse Fernandez. Kcas, Llc look forward to meeting you in Hamburg. Date: October 27 - October 30 Address: CHH - Congress Center Hamburg Congressplatz 1 20355 Hamburg Germany Add to calendar: Meet Kcas, Llc at this event

Recently Posted Jobs

Sign up to get curated job recommendations

KCAS Bio is Hiring for 11 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →